What are the Challenges in Developing Nanovaccines?
Despite their potential, there are several challenges in developing nanovaccines:
Toxicity: Some nanomaterials may pose toxicological risks, necessitating extensive safety evaluations. Production Scale-Up: Scaling up production to meet global demand can be challenging and requires significant investment. Regulatory Hurdles: The regulatory framework for nanovaccines is still evolving, which can delay approvals and commercialization. Cost: The advanced technology and materials used in nanovaccines can make them more expensive to produce.
